RYTHM (NASDAQ:RYM – Get Free Report) is one of 903 publicly-traded companies in the “Pharmaceuticals” industry, but how does it weigh in compared to its peers? We will compare RYTHM to similar businesses based on the strength of its risk, valuation, institutional ownership, profitability, earnings, dividends and analyst recommendations.
Risk & Volatility
RYTHM has a beta of 9.44, indicating that its stock price is 844% more volatile than the S&P 500. Comparatively, RYTHM’s peers have a beta of -3.18, indicating that their average stock price is 418% less volatile than the S&P 500.
Profitability
This table compares RYTHM and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| RYTHM | -6.20% | -12.57% | -2.60% |
| RYTHM Competitors | -2,299.79% | -222.94% | -17.42% |
Valuation and Earnings
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| RYTHM | $17.28 million | -$33.26 million | -2.44 |
| RYTHM Competitors | $3.48 billion | $3.12 billion | 547.14 |
RYTHM’s peers have higher revenue and earnings than RYTHM. RYTHM is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for RYTHM and its peers, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| RYTHM | 1 | 0 | 0 | 0 | 1.00 |
| RYTHM Competitors | 7586 | 13648 | 25434 | 997 | 2.42 |
As a group, “Pharmaceuticals” companies have a potential upside of 29.13%. Given RYTHM’s peers stronger consensus rating and higher possible upside, analysts plainly believe RYTHM has less favorable growth aspects than its peers.
Insider & Institutional Ownership
6.0% of RYTHM shares are owned by institutional investors. Comparatively, 32.8% of shares of all “Pharmaceuticals” companies are owned by institutional investors. 3.5% of RYTHM shares are owned by insiders. Comparatively, 14.2% of shares of all “Pharmaceuticals” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
RYTHM peers beat RYTHM on 9 of the 13 factors compared.
About RYTHM
Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.
Receive News & Ratings for RYTHM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RYTHM and related companies with MarketBeat.com's FREE daily email newsletter.
